Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs > Compugen (CGEN)

6:01AM Compugen announces results showing its CGEN-15001T drug

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
surf1944 Member Profile
 
Followed By 439
Posts 21,541
Boards Moderated 2
Alias Born 09/11/06
160x600 placeholder
Compugen Reacquires Baize’s Financial Interest in Pipeline Product Candidates "Business Wire" - 8/21/2014 7:09:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/21/2014 7:01:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/11/2014 7:00:02 AM
Compugen Ltd. Reports 2nd Quarter 2014 Financial Results "Business Wire" - 8/6/2014 7:11:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/6/2014 7:00:28 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 7/31/2014 4:15:40 PM
Compugen Second Quarter 2014 Conference Call Scheduled for Wednesday, August 6, 2014 a... "Business Wire" - 7/31/2014 7:37:00 AM
Compugen Second Quarter 2014 Conference Call Scheduled for Tuesday, August 5, 2014 at 10:00 AM EDT "Business Wire" - 7/29/2014 7:00:00 AM
Compugen to Present Immune Checkpoint Related Research at Two Scientific Conferences "Business Wire" - 7/24/2014 7:00:00 AM
Compugen Extends Discovery Capabilities to Additional Immunomodulatory Proteins "Business Wire" - 7/14/2014 7:00:00 AM
Compugen Discloses Achievement of Milestone in Cancer Immunotherapy Collaboration with Bayer "Business Wire" - 7/7/2014 7:11:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 7/7/2014 7:01:29 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 6/26/2014 4:20:48 PM
Compugen Discloses Experimental Results for Novel Checkpoint Candidate for Cancer Immunotherapy & Discovery of Two New Candid... "Business Wire" - 6/16/2014 7:00:00 AM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 6/11/2014 5:22:07 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/19/2014 7:06:13 AM
Compugen Ltd. Reports First Quarter 2014 Results "Business Wire" - 5/19/2014 7:00:00 AM
U.S. Hot Stocks: Hot Stocks to Watch "Dow Jones News" - 5/12/2014 8:58:08 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/12/2014 7:01:08 AM
Compugen Appoints Mr. Avihai Shen Interim CFO "Business Wire" - 5/12/2014 7:00:00 AM
Compugen First Quarter 2014 Conference Call Scheduled for Monday, May 19, 2014 at 10:00 AM EST "Business Wire" - 5/5/2014 7:00:00 AM
Compugen to Present at Immunology 2014 Conference "Business Wire" - 4/29/2014 7:30:00 AM
Compugen Says Not Being Investigated in Insider-Trading Probe "Dow Jones News" - 4/7/2014 10:28:32 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 4/7/2014 9:11:39 AM
surf1944   Thursday, 02/02/12 10:57:15 AM
Re: surf1944 post# 109
Post # of 144 
6:01AM Compugen announces results showing its CGEN-15001T drug may have potential for cancer immunotherapy (CGEN) 5.30 : Co announced results demonstrating the therapeutic potential of CGEN-15001T as a drug target for treatment of multiple cancers by means of monoclonal antibody ("mAb") therapy. These results indicate that CGEN-15001T is expressed on numerous types of cancer, such as carcinomas, sarcomas, melanoma and hematological cancers as well as on immune cells. These findings, together with previous results supporting its active immunomodulatory effect, 'strongly support CGEN-15001T's potential as a powerful drug target for treatment of various solid and hematological cancers, an area of great interest to the pharmaceutical industry.'


surf's up......crikey



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist